Jim Murray

Jim Murray

Cardiff University

H-index: 79

Europe-United Kingdom

About Jim Murray

Jim Murray, With an exceptional h-index of 79 and a recent h-index of 38 (since 2020), a distinguished researcher at Cardiff University, specializes in the field of plant cell cycle and development, molecular diagnostics.

His recent articles reflect a diverse array of research interests and contributions to the field:

TSC-100 and TSC-101, TCR-T Cell Therapies That Target Residual Recipient Cells after Reduced Intensity Conditioning Transplantation, Induce Complete Donor Chimerism with …

682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after …

Exercise positively impacts global longitudinal strain in women at risk of developing cardiovascular disease

Impact of Aerobic Training on Cardiovascular Function, Fitness, and Patient Reported Outcomes During Anthracycline Chemotherapy: A Case Series in Women With Breast Cancer

How do practitioners prescribe exercise to patients with breast cancer? Professional perspectives on the key considerations for aerobic exercise in patients with breast cancer …

Initial Results of a Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Prevent Relapse after Allogeneic …

Modelling how plant cell-cycle progression leads to cell size regulation

VarLOCK: sequencing-independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance

Jim Murray Information

University

Position

___

Citations(all)

32237

Citations(since 2020)

6451

Cited By

19539

hIndex(all)

79

hIndex(since 2020)

38

i10Index(all)

181

i10Index(since 2020)

112

Email

University Profile Page

Cardiff University

Google Scholar

View Google Scholar Profile

Jim Murray Skills & Research Interests

plant cell cycle and development

molecular diagnostics

Top articles of Jim Murray

Title

Journal

Author(s)

Publication Date

TSC-100 and TSC-101, TCR-T Cell Therapies That Target Residual Recipient Cells after Reduced Intensity Conditioning Transplantation, Induce Complete Donor Chimerism with …

Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Monzr M Al Malki

Alla Keyzner

Hyung C Suh

Uday R Popat

Nishant Dwivedi

...

2024/2/1

682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after …

Monzr Al Malki

Alla Keyzner

Hyung C Suh

Aasiya Matin

Erica Buonomo

...

2023/11/1

Exercise positively impacts global longitudinal strain in women at risk of developing cardiovascular disease

European Journal of Sport Science

James Murray

Hunter Bennett

Eva Bezak

Rebecca Perry

2023

Impact of Aerobic Training on Cardiovascular Function, Fitness, and Patient Reported Outcomes During Anthracycline Chemotherapy: A Case Series in Women With Breast Cancer

Integrative Cancer Therapies

James Murray

Hunter Bennett

Sudarsha Selva-Nayagam

Rohit Joshi

Eva Bezak

...

2023/11

How do practitioners prescribe exercise to patients with breast cancer? Professional perspectives on the key considerations for aerobic exercise in patients with breast cancer …

Journal of Science and Medicine in Sport

James Murray

Hunter Bennett

Rebecca Perry

Eva Bezak

Kade Davison

2023/12/1

Initial Results of a Phase 1 Trial of TSC-100 and TSC-101, Engineered T Cell Therapies That Target Minor Histocompatibility Antigens to Prevent Relapse after Allogeneic …

Blood

Monzr M Al Malki

Alla Keyzner

Hyung Chan Suh

Aasiya Matin

Erica Buonomo

...

2023/11/28

Modelling how plant cell-cycle progression leads to cell size regulation

PLoS Computational Biology

Daniel Williamson

William Tasker-Brown

James AH Murray

Angharad R Jones

Leah R Band

2023/10/20

VarLOCK: sequencing-independent, rapid detection of SARS-CoV-2 variants of concern for point-of-care testing, qPCR pipelines and national wastewater surveillance

Scientific Reports

Xinsheng Nan

Patrick Hardinge

Sven Hoehn

Shrinivas Nivrutti Dighe

John Ukeri

...

2023/11/27

Product characteristics and clinical trial design for T-Plex: Multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors

Shrikanta Chattopadhyay

Antoine Boudot

Ribhu Nayar

Hannah Bader

Tary Traore

...

2023/6/1

709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors

Shrikanta Chattopadhyay

Antoine J Boudot

Ribhu Nayar

Hannah Bader

Andrew Ferretti

...

2023/11/1

Xinsheng Nan, Patrick Hardinge 1Ε, Sven Hoehn, Shrinivas Nivrutti Dighe, John Ukeri 2, Darius F. Pease 3, Joshua Griffin 3, Jessica I. Warrington, Zack Saud 5, Emma Hottinger 3 …

Scientific Reports

Oliver K Castell

James AH Murray

Tomasz P Jurkowski

2023

A higher spectral range of beetle bioluminescence with infraluciferin

Frontiers in bioengineering and biotechnology

Amit P Jathoul

Bruce R Branchini

James C Anderson

James AH Murray

2022/8/26

The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review

James Murray

Hunter Bennett

Eva Bezak

Rebecca Perry

2022/2/1

Diverted from landfill: reuse of single-use plastic packaging waste

Polymers

Kit O’Rourke

Christian Wurzer

James Murray

Adrian Doyle

Keith Doyle

...

2022/12/15

The impact of breast cancer on fears of exercise and exercise identity

Patient Education and Counseling

James Murray

Rebecca Perry

Emma Pontifex

Sudarsha Selva-Nayagam

Eva Bezak

...

2022/7/1

CUE-102 Selectively Activates and Expands WT1-Specific T Cells for the Treatment of Patients with WT1+ Malignancies

Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting• November

Natasha Girgis

Christie Zhang

Zohra Merazga

Steven Hatfield

Fan Zhao

...

2022

Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus …

Nick Pavlakis

David Turner Ransom

David Wyld

Katrin Marie Sjoquist

Kate Wilson

...

2022/6/1

Enhanced antimicrobial activity of biocompatible bacterial cellulose films via dual synergistic action of curcumin and triangular silver nanoplates

International Journal of Molecular Sciences

Eduardo Lanzagorta Garcia

Marija Mojicevic

Dusan Milivojevic

Ivana Aleksic

Sandra Vojnovic

...

2022/10/13

Major adverse cardiac events (MACE) with immune checkpoint inhibitor (ICI)-based therapies for cancer: A pooled analysis of investigational clinical trials sponsored by the …

Abdul Rafeh Naqash

Melissa Moey

Xiao-Wei Cherie Tan

Mehak Masood Laharwal

Vanessa Hill

...

2022/6/1

Major adverse cardiac events with immune checkpoint inhibitors: A pooled analysis of trials sponsored by the National Cancer Institute—Cancer Therapy Evaluation Program

Journal of Clinical Oncology

Abdul Rafeh Naqash

Melissa YY Moey

Xiao-Wei Cherie Tan

Mehak Laharwal

Vanessa Hill

...

2022/10/10

See List of Professors in Jim Murray University(Cardiff University)